The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Klaram LA 500 mg prolonged-release tablets

500 milligram(s) Prolonged-release tablet

Accord Healthcare Ireland Ltd.PA2315/133/001

Main Information

Trade NameKlaram LA 500 mg prolonged-release tablets
Active SubstancesClarithromycin citrate
Strength500 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/133/001

Group Information

ATC CodeJ01FA Macrolides
J01FA09 clarithromycin

Status

Authorised/WithdrawnAuthorised
Licence Issued05/12/2011
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0072-117-050
Interchangeable List DocumentPDF of Interchangeable List
« Back